- Vyome Holdings, Inc. (formerly ReShape Lifesciences Inc.) completed its merger with Vyome Therapeutics, Inc. on **August 15, 2025**, with Vyome Therapeutics, Inc. surviving as a subsidiary, and the combined company changing its name to Vyome Holdings, Inc..  **[1427570_0001213900-25-082924_ea0254874-8k_vyome.htm:1]** **[1427570_0001213900-25-082924_ea025487401ex99-1_vyome.htm:3]** 
- For the six months ended June 30, 2025, the company reported **revenue of $248,536**, an increase from **$110,990** for the same period in 2024, while the net loss increased to **$(602,732)** from **$(593,132)**.  **[1427570_0001213900-25-082924_ea025487401ex99-1_vyome.htm:0]** 
- The company secured **$7.3 million** in concurrent financing, with **$6.9 million** received in August 2025, and expects to use approximately **$5.0 million** for operating expenses and capital expenditures for up to fifteen months post-merger.  **[1427570_0001213900-25-082924_ea025487401ex99-2_vyome.htm:3]** **[1427570_0001213900-25-082924_ea025487401ex99-1_vyome.htm:15]** 
- The Board of Directors approved a **1-for-5,000 reverse stock split** in August 2025.  **[1427570_0001213900-25-082924_ea025487401ex99-2_vyome.htm:3]** **[1427570_0001213900-25-082924_ea025487401ex99-1_vyome.htm:22]**

Company not found (RSLS)